Trademark: 97590573
Word
ENTOS
Status
Pending
Status Code
681
Status Date
Tuesday, April 2, 2024
Serial Number
97590573
Mark Type
4000
Filing Date
Wednesday, September 14, 2022
Published for Opposition
Tuesday, May 7, 2024

Trademark Owner History

Classifications
9 Nucleic acid sequencers for scientific purposes
5 Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, namely, viral infections, bacterial infections, fungal infections, parasitic infections and prion diseases, infections of multiple organ systems, namely, the lung in the name of pneumonia, kidneys in the name of pyelonephritis, gastrointestinal track in the nature of gastritis, enteritis, colitis, systemic blood infections in the nature of sepsis/septic shock, skin infections in the nature of cellulitis, central nervous system in the nature of meningitis, encephalitis, walled off infections in the nature of abscesses, liver in the nature of hepatitis, head and neck infections in the nature of conjunctivitis, uveitis, sinusitis; chronic diseases, namely, chronic neurological and nervous system diseases and other mental illnesses, chronic respiratory, pulmonary and lung diseases, chronic inflammatory diseases, chronic cardiovascular diseases, chronic liver diseases, chronic kidney diseases, chronic bone diseases, chronic eye diseases, chronic oral diseases, chronic blood diseases, chronic spleen diseases, chronic pancreatic diseases, chronic thyroid diseases, chronic reproductive disease, chronic gastrointestinal diseases, chronic skin diseases, chronic muscle diseases, chronic bone diseases and cancers in the nature of hematological cancers and solid organ cancers; vaccines that are viral, bacterial, fungal for human use; vaccines that are viral, bacterial, fungal for veterinary use; therapeutic and preventative cancer vaccines for human use; therapeutic and preventative cancer vaccines for veterinary use; diagnostic preparations for medical purposes for detecting genetic predispositions; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseases and disorders, namely, cancer, inflammatory diseases and disorders, namely, inflammatory bowel diseases and disorders, inflammatory connective tissue diseases and disorders, inflammatory pelvic diseases and disorders, inflammatory muscle diseases and disorders, asthma, coeliac disease, hepatitis which is viral, alcoholic, autoimmune, inflammatory bowel disease, namely, Crohn's and ulcerative colitis, fatty liver disease, diabetes, endometriosis, arthritis, obesity, autoimmune diseases and disorders, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, genetic diseases and disorders, infectious diseases, namely, blood infections, respiratory infections, topical infections, cardiovascular diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, hematological diseases and disorders, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, eczema, acne, shingles, hives, rosacea, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, namely, urological diseases and disorders, infertility, sexually transmitted diseases, acute renal failure, benign ptostatic hyperplasia, endometrial ablation, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders, rare and orphan diseases, and rare genetic diseases and disorders, namely, rare neurological and nervous system diseases and other mental illnesses, rare respiratory, pulmonary and lung diseases, rare inflammatory diseases, rare cardiovascular diseases, rare liver diseases, rare kidney diseases, rare bone diseases, rare eye diseases, rare oral diseases, rare blood diseases, rare spleen diseases, rare pancreatic diseases, rare thyroid diseases, rare reproductive disease, rare gastrointestinal diseases, rare skin diseases, rare muscle diseases, rare bone diseases; cell culture media for cultivating human, animal, plant or microorganism cells for use in the biotechnological industry
1 Reagents for scientific purposes for use in nucleic acid isolation and purification; cell culture media for laboratory use for use in the biotechnological industry; diagnostic reagents for clinical laboratory use; diagnostic preparations for clinical laboratory use
10 Medical devices for the qualitative detection and testing of DNA and RNA in human specimens for the detection of influenza viruses and nucleic acid detection
The English translation of the word "Entos" in the mark is "within".

Trademark Events
Mar 28, 2024
On Hold - Electronic Record Review Required
Mar 22, 2024
Approved For Pub - Principal Register
Mar 12, 2024
Examiner's Amendment Entered
Mar 11, 2024
Assigned To Lie
Mar 11, 2024
Notification Of Examiners Amendment E-Mailed
Mar 11, 2024
Examiners Amendment E-Mailed
Mar 11, 2024
Examiners Amendment -Written
Mar 8, 2024
Divisional Processing Complete
Nov 16, 2023
Divisional Request Received
Mar 6, 2024
Case Assigned To Intent To Use Paralegal
Nov 16, 2023
Teas Response To Office Action Received
Nov 16, 2023
Preliminary/Voluntary Amendment - Entered
Nov 16, 2023
Teas Voluntary Amendment Received
Nov 16, 2023
Teas Request To Divide Received
Sep 27, 2023
Application Extension Granted/Receipt Provided
Sep 27, 2023
Application Extension To Response Period - Received
Jun 27, 2023
Notification Of Non-Final Action E-Mailed
Jun 27, 2023
Non-Final Action E-Mailed
Jun 27, 2023
Non-Final Action Written
Jun 26, 2023
Assigned To Examiner
Sep 29, 2022
New Application Office Supplied Data Entered
Sep 17, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24